Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

670
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
670
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

783
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
783

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transport of Engineered Nanoparticles in Solid Tumors: Mechanistic Barriers and Emerging Delivery Strategies.

Bioconjugate chemistry·2026
Same author

Decoding polyamine-ethylene dynamics: synergies at synthesis and signalling levels during osmotic stress and ripening.

Frontiers in plant science·2026
Same author

Rethinking the Risk: A Case-Control Study on the Low Prevalence of Established Breast Cancer Risk Factors in Young Indian Women.

Indian journal of surgical oncology·2026
Same author

Cu-porphyrin PCN-222 MOF hybridized with Au nanoclusters to accelerate electron transfer for ultrasensitive detection of 25-hydroxyvitamin D<sub>3</sub>.

Bioelectrochemistry (Amsterdam, Netherlands)·2026
Same author

Micelle-Assisted Lewis and Brønsted Acid Catalysis: A Review Towards Greener and Efficient Synthesis of Polycyclic and Heteroaromatic Compounds.

Molecules (Basel, Switzerland)·2026
Same author

Taking microvascular training through the elevator: institutional experience in structured microsurgical training in India.

Maxillofacial plastic and reconstructive surgery·2026

Related Experiment Video

Updated: Apr 7, 2026

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
08:49

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

Published on: August 2, 2024

1.5K

Revascularization in Severe Left Ventricular Dysfunction: Does Myocardial Viability Even Matter?

Pahul Singh1, Nishant Sethi1, Navneet Kaur2

  • 1Fellow in Cardiovascular disease, SUNY Upstate Medical University Syracuse, NY, USA.

Clinical Medicine Insights. Cardiology
|July 10, 2015
PubMed
Summary

Assessing myocardial viability helps identify patients with coronary artery disease and left ventricular dysfunction who benefit from revascularization. This improves heart function and prognosis, guiding treatment decisions.

Keywords:
left ventricular dysfunctionmyocardial viabilityrevascularization

More Related Videos

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats
06:32

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats

Published on: June 28, 2019

8.6K
Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
07:24

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR

Published on: April 8, 2013

24.8K

Related Experiment Videos

Last Updated: Apr 7, 2026

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
08:49

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

Published on: August 2, 2024

1.5K
Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats
06:32

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats

Published on: June 28, 2019

8.6K
Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
07:24

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR

Published on: April 8, 2013

24.8K

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Interventional Cardiology

Background:

  • Left ventricular dysfunction is a key prognostic indicator in coronary artery disease (CAD).
  • Ischemic cardiomyopathy, a common complication of CAD, presents a significant clinical challenge and healthcare cost.
  • Coronary revascularization can improve symptoms, prognosis, and left ventricular remodeling in select patients.

Purpose of the Study:

  • To review modalities for assessing myocardial viability.
  • To evaluate the clinical impact of revascularization based on myocardial viability evidence in patients with left ventricular dysfunction.

Main Methods:

  • Review of existing literature on myocardial viability assessment techniques.
  • Analysis of clinical outcomes following revascularization in patients with documented viable myocardium.

Main Results:

  • Myocardial viability assessment is crucial for patient selection in revascularization procedures.
  • Evidence of viable myocardium predicts improved functional recovery and prognostic benefits post-revascularization.
  • Different imaging modalities offer varying insights into myocardial viability.

Conclusions:

  • Identifying viable myocardium is essential for optimizing revascularization strategies in ischemic left ventricular dysfunction.
  • Revascularization in patients with viable myocardium leads to significant improvements in left ventricular function and patient outcomes.
  • Further research into advanced viability assessment techniques can refine patient selection and treatment efficacy.